FOXM1 confers acquired cisplatin resistance in breast cancer cells - Wikidata - awgldk - TriplyDB

FOXM1 confers acquired cisplatin resistance in breast cancer cells

FOXM1 confers acquired cisplatin resistance in breast cancer cells

http://www.wikidata.org/entity/Q24642596

about

sameAs

Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes Phosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis The Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to Therapy FOXM1: an emerging master regulator of DNA damage response and genotoxic agent resistance Exploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosis 3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cells Peroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cells Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank.FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cells FOXM1 modulates cisplatin sensitivity by regulating EXO1 in ovarian cancer Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Increased FOXM1 expression can stimulate DNA repair in normal hepatocytes in vivo but also increases nuclear foci associated with senescence.FoxM1 mediates resistance to herceptin and paclitaxel.FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage.Chronic treatment with cisplatin induces replication-dependent sister chromatid recombination to confer cisplatin-resistant phenotype in nasopharyngeal carcinoma.Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo.Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer.FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.Small molecule inhibition of FOXM1: How to bring a novel compound into genomic context Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.FoxM1 regulates mammary luminal cell fate OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment.JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells.Forkhead box protein M1 predicts outcome in human osteosarcoma A Gene Regulatory Program in Human Breast Cancer A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS

P2860

Q21245703-9BE8A298-1E63-424B-BCBF-8EBCEB1633ED Q24301472-B2ABC4D5-459C-46BA-A823-4DDCD2838CB3 Q24613046-5A7E6F4D-E7A4-4DB1-A451-383083ABBD86 Q26768290-9E2E7553-88E8-4D72-AE54-1DAA8FE2852D Q26864654-D0B15C7D-C067-4BE0-AD69-B192983B560D Q28276344-187EF84B-C6C3-4616-81AC-4EE214AB278C Q28485231-DE7BDF97-213D-4283-927B-F9E1D41360EA Q28728015-294D71D4-F13A-4323-8A29-F1B707FAEB6A Q33456377-044C797B-0E00-4157-B7AD-E2B34D5DA6CA Q33567379-37A54D6E-2EB5-4344-841F-8F7425BB663B Q33605013-9F8A10EB-78C2-4A89-9AEA-C903FA21F48D Q33670486-50BFA79E-281F-42D6-B394-7FCD4AB830C5 Q33924107-31A52838-BCA5-4CA0-87E0-4958F51D79CB Q33946664-8E9C40EE-4856-4FAB-8452-8CF0B1DDD125 Q33991617-CCBAAC75-04EF-46E8-B5E2-CAC26D974AD9 Q34000057-544EC7AE-399A-4E05-AE01-18E17C9F1DE2 Q34185710-1BC01D6A-EA91-4AF5-A32D-A438E8585128 Q34227706-C62466F2-E0F9-46A9-8B0D-F6071EAEC814 Q34550042-879E0A85-964C-4E0B-B096-A99D554F971D Q34573492-11D9E70F-A21F-4DAD-AB42-2491CCEB9602 Q34649774-8B61788B-C34E-426F-AD59-83BC0661561F Q34664059-B035D4A4-1CB6-4068-93E9-301939D12FAD Q34956879-45EBAA28-F077-4F3D-BBAE-DE30FA9ECA31 Q35080145-8305AA2A-54C0-4D66-8A17-D63EE312D79B Q35168154-55793625-5FFA-44E6-8698-7C85969C8763 Q35273654-AAB57483-3F5B-47C4-B170-E165D1A09A65 Q35410253-08B5A596-7D6D-47B2-9B5C-A83190294979 Q35764362-D207119F-84FE-42BC-A827-5EE5D2CE335F Q35793788-7487A4A4-0D6A-4453-B9AB-B8B651BF0116 Q35800767-45927E5D-4809-4CC7-A636-394AD8E77DD4 Q35951768-95B06D9B-4461-4AEB-BB49-A7B9134D4589 Q35962063-93226906-2F1C-4B83-AF16-C7113045E731 Q36106731-8F3A00C9-2C33-42FE-923A-6E0F62D3CA31 Q36165185-7D276212-5B88-4F23-B141-D17FAC41A814 Q36249356-0E615DA0-8A36-4E8E-8378-3B8246DB4F82 Q36291991-E594548B-C9AA-4437-9CB4-CF33F6A7C55E Q36293810-4D20B7B0-1262-4059-A3B9-5C38796EB0AC Q36317582-0FD83CB5-D308-422B-B2DA-D1FBEB4E23D2 Q36365236-F0699744-B8FB-46D3-9528-8C0804FBEF3E Q36419222-E2BC1676-CD4D-4C41-BE96-B35577784214

P2860

FOXM1 confers acquired cisplatin resistance in breast cancer cells

http://www.wikidata.org/entity/Q24642596

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

FOXM1 confers acquired cisplatin resistance in breast cancer cells

@ast

FOXM1 confers acquired cisplatin resistance in breast cancer cells

@en

FOXM1 confers acquired cisplatin resistance in breast cancer cells

@nl

type

label

FOXM1 confers acquired cisplatin resistance in breast cancer cells

@ast

FOXM1 confers acquired cisplatin resistance in breast cancer cells

@en

FOXM1 confers acquired cisplatin resistance in breast cancer cells

@nl

prefLabel

FOXM1 confers acquired cisplatin resistance in breast cancer cells

@ast

FOXM1 confers acquired cisplatin resistance in breast cancer cells

@en

FOXM1 confers acquired cisplatin resistance in breast cancer cells

@nl

P1433

Q24642596-74B2A208-934B-46CE-9E02-47ADAED9C3BE

P1476

Q24642596-38AF6BC8-9038-4BED-8649-85291AC9B041

P2093

Q24642596-1C58396E-76C1-4841-B861-396432E0883D

Q24642596-1D29E8D6-1D89-4E73-A465-761BE618288D

Q24642596-26C5185F-7ADF-4D36-825A-DEC5BE335D68

Q24642596-59139133-56C1-4EF0-A235-A5B3DEFFC21B

Q24642596-F546BF47-965B-44D0-8173-58E62AE614F2

Q24642596-FC26A3EA-B705-414B-9D20-C08B73B4C716

P2860

Q24642596-15937873-C4D6-4E5B-B0A0-EFB3C0ACEFD9

Q24642596-22378E5B-819C-4861-A6E5-87F3B5672E44

Q24642596-2E950515-12D0-48B5-8209-FA2ACEFC5C31

Q24642596-2F1AA17B-1A88-47CC-9C9A-1BC70FCF646A

Q24642596-387E79CC-512B-4488-B549-B3A20ED41667

Q24642596-39BDD0ED-EBDE-4E1D-82E6-5C6183A77A94

Q24642596-3AD5D24C-2D6E-4C36-885B-AB54E5C41407

Q24642596-407C527C-FCC2-4987-847C-981C82B6714C

Q24642596-41C92028-6796-4C73-B0D4-AF9D5137E659

Q24642596-50FEBA05-9BE8-47A9-BDDB-DCD979B3E1D5

P304

Q24642596-F3D5EE65-CE14-45C2-9B07-029148561162

P31

Q24642596-BF7184F7-7955-4F4F-BF50-B6AB9397476D

P3181

Q24642596-85D270DA-8932-4938-814D-70216B22A32B

P356

Q24642596-73786FD6-4FC6-4569-A50E-BC2237BDD87C

P407

Q24642596-7F36332B-CE59-45F8-AF67-8FBDC04A84A2

P433

Q24642596-160D74F5-21E8-4BA4-B74F-C892BE2BBEFA

P478

Q24642596-1211F496-960F-49C1-A81A-C376E72EA1C5

P50

Q24642596-AC8C3590-939B-4D16-AC17-7159A0A32FBB

Q24642596-E0CB08C0-CD9C-4DE2-89BB-A652DF86F74F

P577

Q24642596-9DA0DEE8-1606-4039-B80A-CE9E621C01F2

P5875

Q24642596-E6608AB7-1B37-4D40-86B1-D92B5E228344

P698

Q24642596-C3C6B003-7891-446E-A28C-B4D79F8763B7

P932

Q24642596-7CA80CFC-FA80-4F87-AE09-9F2E3D02AE67

P3181

P356

1541-7786.MCR-09-0432

P1433

Molecular Cancer Research

P1476

FOXM1 confers acquired cisplatin resistance in breast cancer cells

@en

P2093

Helma D C Schwenen

http://www.w3.org/2001/XMLSchema#string

Jimmy M-M Kwok

http://www.w3.org/2001/XMLSchema#string

Julie Millour

http://www.w3.org/2001/XMLSchema#string

Lara J Monteiro

http://www.w3.org/2001/XMLSchema#string

R Charles Coombes

http://www.w3.org/2001/XMLSchema#string

Stephen S Myatt

http://www.w3.org/2001/XMLSchema#string

P2860

Inducible degradation of checkpoint kinase 2 links to cisplatin-induced resistance in ovarian cancer cells

CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer

The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells

Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes

The human TRIDENT/HFH-11/FKHL16 gene: structure, localization, and promoter characterization

Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells

Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe

Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Hallmarks of 'BRCAness' in sporadic cancers

P304

24-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4084154

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1541-7786.MCR-09-0432

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41000736

http://www.w3.org/2001/XMLSchema#string

P698

20068070

http://www.w3.org/2001/XMLSchema#string

P932

2809047

http://www.w3.org/2001/XMLSchema#string